Nexalin Technology (NXL) Asset Utilization Ratio (2022 - 2026)
Nexalin Technology (NXL) posted Asset Utilization Ratio of 0.06 for Q2 2026, down 2.01% on a QoQ basis from 0.07 in Q1 2026, and up 75.5% year-over-year from 0.04 in Q2 2025.
Powered by 
Analysis
Nexalin Technology (NXL) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Nexalin Technology has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.06 in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio rose 75.5% year-over-year to 0.06 in Q2 2026; TTM through Jun 2026 was 0.06, a 75.5% increase from a year earlier, with the FY2025 full-year figure at 0.07, up 58.53% from the prior year.
- Asset Utilization Ratio was 0.06 for Q2 2026 at Nexalin Technology, down from 0.07 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.17 in Q4 2022, with the low at 0.03 in Q3 2023.
- Average Asset Utilization Ratio over 5 years is 0.07, with a median of 0.05 recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio tumbled 83.6% in 2023, then soared 79.79% in 2026.
- Over 5 years, Asset Utilization Ratio stood at 0.17 in 2022, then sank by 83.6% to 0.03 in 2023, then gained by 29.62% to 0.04 in 2024, then surged by 73.63% to 0.06 in 2025, then increased by 4.9% to 0.06 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.06 (Q2 2026), 0.07 (Q1 2026), and 0.06 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 0.42 |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 0.54 |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 0.40 |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 0.55 |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 0.47 |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 0.48 |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.34 |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 0.76 |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 0.56 |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 | 0.06 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.06 |
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.12 |
| Mar 31, 2023 | 0.15 |
| Dec 31, 2022 | 0.17 |